CDMO Specialist - Upperton Pharma Solutions

Your new CDMO partner.

Integrated CDMO services to accelerate and de-risk your drug product journey.

Why choose Upperton?

Proven track record

Spray drying expertise

Open dialogue

Science-led approach

Unparalleled delivery.

At Upperton, your molecule reigns supreme. We pledge an unwavering commitment to prioritising your project.

Our expansive project team covers every layer of our operations, ensuring a thorough and dedicated approach tailored to your needs.

With extensive experience, our Leadership Team excels in steering products from pre-clinical to late-stage manufacture. This extensive expertise forms the cornerstone of our service to you, guaranteeing your project benefits from seasoned guidance and hands-on involvement at every stage.

Flexible and nimble.

Our defining traits lie in our adaptability and nimbleness, allowing us to swiftly align with your evolving needs.

As a CDMO like no other, our flexibility ensures that we can meet your demands and expectations promptly.

Count on us to navigate the complexities of your project with precision, leveraging our unique approach and swift response to deliver optimal results.

Capacity to match your needs.

Situated in Nottingham, UK, our expansive 50,000 sqft R&D, Analysis, and GMP manufacturing site serves as the hub for innovation and excellence.

With a robust infrastructure and specialised teams, we take pride in offering seamless scale-up and full-spectrum project delivery, covering the entire journey from pre-clinical stages and formulation development, to late-phase development and analytical services.

Partnering with us means accessing a wealth of knowledge and resources to bring your project from inception to realisation.

Award-winning

Achieve your drug program goals
with one integrated CDMO partner.

Pre-Clinical Development

Formulation development, prototype screening and stability, method development and qualification.

Phase 1 -2 Clinical Supply

Phase 1 – 2 clinical manufacturing, QC testing, ICH stability, Qualified Person Release, Clinical Stability.

Process Scale-Up for Phase 3

Process robustness (DoE), method validation, cleaning validation, ICH stability, QP release.

Registration

Scale-up and batch manufacture, NDA/BLA submission, process QbD, full stability studies, risk assessements.

Process Validation & Launch

Manufacture of launch supplies, stability studies, NDA QC dissolution method and CR dissolution.

Regulatory Support

CMC strategy, gap analysis and classifications, regulatory agency support, marketing applications.

Meet our Leadership Team

Nikki Whitfield, Chief Executive Officer
Nikki has 28 years’ technical and operational leadership experience gained in both Pharmaceutical Companies and Contract Development and Manufacturing Organisations.

Richard Johnson, Founder & CSO
Dr Richard Johnson founded Upperton Pharma Solutions in August 1999, and has over 30 years of experience in the pharmaceutical, biotechnology and drug delivery fields.

Ian Lafferty, Chief Technical Officer
Ian has 25 years’ technical, operational experience gained in early phase pharmaceutical development, encompassing the formulation design and development, process optimisation and manufacture of a wide range of dosage forms.

Paul Kelsall, Director of Clinical Manufacturing
Paul joined Upperton Pharma Solutions in August 2018. Paul has over 20 years of experience in the pharmaceutical industry, having previously worked for Boots, Reckitt Benckiser, Nova Laboratories and Aesica.

Laura Mason, Director of Pharmaceutical Sciences
Dr Laura joined Upperton in 2016. Laura has previous experience within solid oral dosage form development having completed her PhD in the School of Pharmacy at the University of Nottingham, and her Pharmacy Pre-Registration Year at Merck Sharp and Dohme and Guy’s & St Thomas’ Hospital. Laura is a UK Registered Pharmacist.

Helen Gisby, Director of Analytical Services
Helen joined Upperton Pharma Solutions in September 2021 and has over 30 years experience in the pharmaceutical industry.

Jon Austwick, Director of Quality and Compliance
Jon joined Upperton Pharma solutions in June 2022 and has over 20 years Quality Assurance experience within the pharmaceutical and medical device industries. Jon has held Quality leadership roles within global healthcare companies including Smith and Nephew, Reckitt and BCM Fareva.

Jamie Roberts, Chief Financial Officer
Jamie is a chartered accountant with over 20 years of experience in the food and construction industry. As well as holding a number of Senior Finance roles during his career Jamie has also led commercial and operational teams, as well as supporting and developing People and IT strategies.

Lisa Roberts, Head of Business Operations
Lisa has over 15 years’ experience within the pharmaceutical industry and joined in November 2021. Lisa has previously held senior roles within pharmaceutical development, business development and commercial operations covering all aspects of drug development and clinical research from early stage to late stage projects.

Niki Beer, Human Resources Manager
Niki joined Upperton Pharma Solutions in March 2023. With over 15 years’ experience in HR, Niki is a results-focused leader who works collaboratively with senior managers taking initiative and engaging with teams to achieve successful outcomes.